Video+

In this video interview, diabetes specialist John Wilding discusses how the CREDENCE trial findings may impact the treatment of people with type 2 diabetes and chronic kidney disease (3:31).

Nephrologist and Endocrinologist Katherine Tuttle joins Primary Care Physician Jay Shubrook to share best practice tips for kidney disease screening in patients with diabetes (8:16).

Psychological Wellbeing Practitioner Abeni Lüken outlines the patient engagement techniques that healthcare practitioners can use to facilitate open and positive discussions about eating disorders (4:08).

Roy Taylor explains why the DiRECT intervention may benefit a surprisingly wide variety of people, and how the trial’s findings could trigger a major shift in thinking about how to tackle type 2 diabetes (6:45).

Amar Puttanna highlights the key clinical messages that have come out of the DiRECT trial (0:59).

John Wilding discusses the implications of the 2-year outcomes of the DiRECT trial, and the questions that remain unanswered (4:17).

Ophthalmologist Philip Burgess joins Clinical Diabetologist John Wilding to discuss the treatment of sight-threatening retinopathy and maculopathy in people with diabetes (9:11).

Ophthalmologist Philip Burgess joins Clinical Diabetologist John Wilding to discuss the disease processes that lead to retinopathy in people with diabetes (9:11).

Ophthalmologist Philip Burgess joins Clinical Diabetologist John Wilding to discuss diabetic retinopathy screening and the key role that it plays in reducing vision loss among people with diabetes (10:00).

Editorial board member Lori Berard gives her take-home messages from the 2019 ATTD conference (1:42).

Korey Hood discusses his research looking at the effects on patients and carers of starting continuous glucose monitoring straight after diabetes diagnosis (4:25).

Tim Jones explains why psychosocial research matters to clinicians, and discusses a randomized trial of continuous glucose monitoring from the point of diabetes diagnosis (3:11).

Korey Hood outlines some psychologic issues that should be addressed to optimize the uptake of diabetes technologies by adolescents (4:46).

Simon Heller outlines some straightforward tactics for assessing people’s risk for hypoglycemia during routine consultations (2:49).

Kath Barnard talks about why is it important to feature psychologic research and patient-reported outcomes at a diabetes technology conference (1:44).

Engineer and endocrinologist Rayhan Lal, from Stanford University in California, USA, explains the phenomenon of DIY closed-loop insulin delivery and what to do if a patient wants to adopt it.

With the use of insulin pumps and related technologies expected to increase among pregnant women with type 1 diabetes, Pratik Choudhary and Lori Berard discuss management protocols for women admitted to maternity units (4:26).

Pratik Choudhary and Lori Berard discuss considerations for treating diabetes device users admitted for surgical procedures and radiological investigations (11:41).

Lori Berard and Pratik Choudhary address situations that can lead to emergency department admissions in patients using diabetes devices and discuss management strategies tailored to this patient population (9:36).

Lori Berard and Pratik Choudhary address situations that can lead to hospital admissions in insulin pump users, and discuss what the treating clinician needs to know (8:42).